Press Release: Velico : Velico Medical Announces BARDA Exercise of $15.5 Million Contract Option

BARDA has extended its Spray Dried Plasma development contract with Velico Medical through March 2017 providing for an additional $15.5 million. Spray dried plasma is being developed as an alternative to frozen plasma and is expected to play an important role wherever time to plasma transfusion is critical to patient care.(PRWeb September 09, 2015)Read the full story at http://www.prweb.com/releases/2015/09/prweb12950738.htm